Sunshine Heart intends to price public offering of its common shares

Bookrunner Canaccord Genuity assists; deal funds corporate purposes

By Devika Patel

Knoxville, Tenn., April 10 - Sunshine Heart, Inc. plans to price a public sale of common stock with a 30-day greenshoe option, according to a preliminary prospectus supplement filed Wednesday with the Securities and Exchange Commission.

Canaccord Genuity is the sole-bookrunning manager.

Proceeds will be used for general corporate purposes and clinical trial and product development activities.

Based in Eden Prairie, Minn., Sunshine Heart produces the C-Pulse, a mechanical heart assistance device.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.